Literature DB >> 3100446

[Experiences with L-carnitine in the post-stress phase].

D Balogh, J M Hackl, E Legenstein, H E Musil.   

Abstract

A prospective randomized double blind investigation was made in 24 multiple injured patients. All patients were treated with a combined parenteral-enteral nutrition during 7 days. A group of 11 patients received as a continuous infusion over 16 h 60 mg/kg BW carnitine daily. Beside carnitine and acetylcarnitine levels in plasma and urine the following parameters were determinated to evaluate the effect of carnitine: for the metabolism of fatty acids: triglycerides, free fatty acids (FFA), alpha-hydroxy-butyrate for the metabolism of carbohydrates: glucose, insulin and lactate in plasma. Finally for amino acid metabolism: urea, creatinine, cholinesterase and kolloid osmotic pressure in plasma as well as ureanitrogen and alpha-aminonitrogen excretion in urine. In the patients receiving carnitine especially acetyl-carnitine in plasma and acetyl-carnitine excretion in urine increased, proving that the administered carnitine can pass through the mitochondrial membrane. In these patients the plasma level of FFA was markedly lower than in the group without carnitine. Simultaneously the level of the alpha-hydroxybutyrate was elevated, equivalent to an increased oxydation of fatty acids. There was no difference between the two groups in the metabolism of carbohydrates. Administration of carnitine caused a slight increase of the production of urea (PU), catabolism could not be reduced. The excretion of alpha-aminonitrogen in urine augmented after carnitine infusion. Carnitine is an AA itself and so the amount of excreted alpha-amino nitrogen will increase; additionally the reabsorption of AA in the proximal renal tubulus may be inhibited by carnitine.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3100446

Source DB:  PubMed          Journal:  Infusionsther Klin Ernahr        ISSN: 0378-0791


  2 in total

Review 1.  l-Carnitine. A preliminary review of its pharmacokinetics, and its therapeutic use in ischaemic cardiac disease and primary and secondary carnitine deficiencies in relationship to its role in fatty acid metabolism.

Authors:  K L Goa; R N Brogden
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

2.  [Effect of L-carnitine supplemented total parenteral nutrition on postoperative lipid and nitrogen utilization].

Authors:  C Rössle; C Pichard; M Roulet; R Chiolero; Y Schutz; E Temler; C Schindler; F Zurlo; E Jéquier; P Fürst
Journal:  Klin Wochenschr       Date:  1988-12-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.